共 18 条
[1]
Antithbrombotic therapy in atrial fibrillation:American College of Chest Physicians Evidence-Based Clincal Practice Guidelines(8th Edition). Singer DE,,Albers GW,Dalen JE,et al. Chest . 2008
[2]
Antithrombotic and thrombolytic therapy for ischemic stroke:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines(8th Edition). Albers GW,Amarenco P,Easton JD,et al. Chest . 2008
[3]
Fast assessment of stroke and transient ischaemic attack to prevent early recurrence(FASTER):a randomised controlled pilot trial. Kennedy J,Hill MD,Ryckborst KJ,Eliasziw M,Demchuk AM,Buchan AM,et al. The Lancet Neurology . 2007
[4]
Terutroban versus aspirin in patients with cerebral ischaemic events(PERFORM):a randomised,double-blind,parallel-group trial. Bousser MG,Amarenco P,Chamorro A,et al. The Lancet . 2011
[5]
The International Stroke Trial(IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischemic stroke. International Stroke Trial Collaborative Group. The Lancet . 1997
[6]
Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. European Atrial Fibrillation Trial Study Group. The Lancet . 1993
[7]
A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). CAPRIE Steering Committee. The Lancet . 1996
[8]
Antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks. Koudstaal P J. Cochrane Database of Systematic Reviews . 2000
[9]
Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial.On behalf of the CAST and IST collaboratlve groups. Chen ZM,Sandercock P,Pan HC,et al. Stroke . 2000
[10]
Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial[J] . Reinhard Dengler,Hans-Christoph Diener,Andreas Schwartz,Martin Grond,Helmut Schumacher,Thomas Machnig,Christoph Cyrill Eschenfelder,Joachim Leonard,Karin Weissenborn,Andreas Kastrup,Roman Haberl.  Lancet Neurology . 2010 (2)